Join
Live feed
·
PRReleasevia Quantisnow
BIO-key International Inc. logo

Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET

ByQuantisnow·Wall Street's wire, on your screen.
BKYI· BIO-key International Inc.
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BKYI (BIO-key International Inc.) and more on Quantisnow.